Article

CA125 serum levels in BRCA1/BRCA2 pathogenic sequence variant carriers as an ovarian cancer screening tool– a longitudinal study

2024-05-31

Abstract excerpt

<title>Abstract</title> <p><italic>BRCA1/BRCA2</italic> female pathogenic sequence variant (PSV) carriers in Israel are offered semiannual CA125 serum level determination and transvaginal ultrasound, until risk reducing salpingooophorectomy (RRSO). The value of longitudinal CA125 measurements in <italic>BRCA1/BRCA2</italic> carriers as a tool for ovarian cancer detection is reported herein. Asymptomatic <italic>B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 68a5db62-7d13-5db1-a33a-c4fb1c09a795
DOI: 10.21203/rs.3.rs-4440317/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CA125 serum levels in BRCA1/BRCA2 pathogenic sequence variant carriers as an ovarian cancer screening tool– a longitudinal studyDOI 10.21203/rs.3.rs-4440317/v1Read

Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system.Semantic proximity Read

Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers- A single institution experienceSemantic proximity Read

Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read

Pregnancy Associated Breast Cancer Among Israeli BRCA1/BRCA2 Carriers in a High-Risk Clinic.Semantic proximity Read

Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.Semantic proximity Read

Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.Semantic proximity Read

Factors influencing uptake of risk-reducing mastectomy among unaffected Israeli BRCA1/BRCA2 pathogenic variant carriersSemantic proximity Read

Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: Results from EMBRACESemantic proximity Read

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.Semantic proximity Read

Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience.Semantic proximity Read

Screening strategies for prostate cancer in Israeli BRCA pathogenic sequence variant carriersSemantic proximity Read

Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.Semantic proximity Read